Jump to content

3,4-Methylenedioxy-N-methoxyamphetamine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
CAS#
No edit summary
Line 38: Line 38:


[[Category:Psychedelic phenethylamines]]
[[Category:Psychedelic phenethylamines]]
[[Category:Amphetamines]]



{{Psychoactive-stub}}
{{Psychoactive-stub}}

Revision as of 07:03, 15 September 2009

3,4-Methylenedioxy-N-methoxyamphetamine
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
Identifiers
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NOC)OCO2
Properties
C11H15NO3
Molar mass 209.242 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

MDMEO, or 3,4-methylenedioxy-N-methoxyamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.

See also

Template:PiHKAL